BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta A, Kafetzis KN, Tagalakis AD, Yu-Wai-Man C. RNA therapeutics in ophthalmology - translation to clinical trials. Exp Eye Res 2021;205:108482. [PMID: 33548256 DOI: 10.1016/j.exer.2021.108482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ben-arzi A, Ehrlich R, Neumann R. Retinal Diseases: The Next Frontier in Pharmacodelivery. Pharmaceutics 2022;14:904. [DOI: 10.3390/pharmaceutics14050904] [Reference Citation Analysis]
2 Yang B, Li G, Liu J, Li X, Zhang S, Sun F, Liu W. Nanotechnology for Age-Related Macular Degeneration. Pharmaceutics 2021;13:2035. [PMID: 34959316 DOI: 10.3390/pharmaceutics13122035] [Reference Citation Analysis]
3 Adachi H, Hengesbach M, Yu YT, Morais P. From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies. Biomedicines 2021;9:550. [PMID: 34068948 DOI: 10.3390/biomedicines9050550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Anthony K. RNA-based therapeutics for neurological diseases. RNA Biol 2022;19:176-90. [PMID: 35067193 DOI: 10.1080/15476286.2021.2021650] [Reference Citation Analysis]
5 Sanghani A, Andriesei P, Kafetzis KN, Tagalakis AD, Yu-Wai-Man C. Advances in exosome therapies in ophthalmology-From bench to clinical trial. Acta Ophthalmol 2021. [PMID: 34114746 DOI: 10.1111/aos.14932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moumné L, Marie A, Crouvezier N. Oligonucleotide Therapeutics: From Discovery and Development to Patentability. Pharmaceutics 2022;14:260. [DOI: 10.3390/pharmaceutics14020260] [Reference Citation Analysis]
7 Rasoulinejad SA, Maroufi F. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Mol Biotechnol 2021;63:768-79. [PMID: 34057656 DOI: 10.1007/s12033-021-00345-4] [Reference Citation Analysis]
8 Zuzic M, Striebel J, Pawlick JS, Sharma K, Holz FG, Busskamp V. Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors. Prog Retin Eye Res 2022;:101065. [PMID: 35562270 DOI: 10.1016/j.preteyeres.2022.101065] [Reference Citation Analysis]
9 Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H, Yang X, Liu L. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective. Int J Nanomedicine 2021;16:6497-530. [PMID: 34588777 DOI: 10.2147/IJN.S329831] [Reference Citation Analysis]